Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites.

Tamura H, Kohchi C, Yamada R, Ikeda T, Koiwai O, Patterson E, Keene JD, Okada K, Kjeldsen E, Nishikawa K, et al.

Nucleic Acids Res. 1991 Jan 11;19(1):69-75.

2.

Identification of mutations at DNA topoisomerase I responsible for camptothecin resistance.

Wang LF, Ting CY, Lo CK, Su JS, Mickley LA, Fojo AT, Whang-Peng J, Hwang J.

Cancer Res. 1997 Apr 15;57(8):1516-22.

3.

Altered topoisomerase I expression in two subclones of human CEM leukemia selected for resistance to camptothecin.

Kapoor R, Slade DL, Fujimori A, Pommier Y, Harker WG.

Oncol Res. 1995;7(2):83-95.

PMID:
7579731
4.

Cloning of Chinese hamster DNA topoisomerase I cDNA and identification of a single point mutation responsible for camptothecin resistance.

Tanizawa A, Beitrand R, Kohlhagen G, Tabuchi A, Jenkins J, Pommier Y.

J Biol Chem. 1993 Dec 5;268(34):25463-8.

5.

Identification and characterization of a deletion mutant of DNA topoisomerase I mRNA in a camptothecin-resistant subline of human colon carcinoma.

Yanase K, Sugimoto Y, Tsukahara S, Oh-Hara T, Andoh T, Tsuruo T.

Jpn J Cancer Res. 2000 May;91(5):551-9.

PMID:
10835501
6.

Characterization of a novel topoisomerase I mutation from a camptothecin-resistant human prostate cancer cell line.

Urasaki Y, Laco GS, Pourquier P, Takebayashi Y, Kohlhagen G, Gioffre C, Zhang H, Chatterjee D, Pantazis P, Pommier Y.

Cancer Res. 2001 Mar 1;61(5):1964-9.

7.

Novel mutation of topoisomerase I in rendering cells resistant to camptothecin.

Chang JY, Liu JF, Juang SH, Liu TW, Chen LT.

Cancer Res. 2002 Jul 1;62(13):3716-21.

9.

Development of a stable camptothecin-resistant subline of P388 leukemia with reduced topoisomerase I content.

Eng WK, McCabe FL, Tan KB, Mattern MR, Hofmann GA, Woessner RD, Hertzberg RP, Johnson RK.

Mol Pharmacol. 1990 Oct;38(4):471-80.

PMID:
2172765
10.

Mutation at the catalytic site of topoisomerase I in CEM/C2, a human leukemia cell line resistant to camptothecin.

Fujimori A, Harker WG, Kohlhagen G, Hoki Y, Pommier Y.

Cancer Res. 1995 Mar 15;55(6):1339-46.

11.

Identification of a mutant human topoisomerase I with intact catalytic activity and resistance to 9-nitro-camptothecin.

Rubin E, Pantazis P, Bharti A, Toppmeyer D, Giovanella B, Kufe D.

J Biol Chem. 1994 Jan 28;269(4):2433-9.

13.
14.

Camptothecin resistance from a single mutation changing glycine 363 of human DNA topoisomerase I to cysteine.

Benedetti P, Fiorani P, Capuani L, Wang JC.

Cancer Res. 1993 Sep 15;53(18):4343-8.

15.

Domain interactions affecting human DNA topoisomerase I catalysis and camptothecin sensitivity.

Fiorani P, Amatruda JF, Silvestri A, Butler RH, Bjornsti MA, Benedetti P.

Mol Pharmacol. 1999 Dec;56(6):1105-15.

16.
17.

Characterization of camptothecin-resistant Chinese hamster lung cells.

Chang JY, Dethlefsen LA, Barley LR, Zhou BS, Cheng YC.

Biochem Pharmacol. 1992 Jun 9;43(11):2443-52. Erratum in: Biochem Pharmacol 1993 Feb 9;45(3):787.

PMID:
1319161
18.

The camptothecin-resistant topoisomerase I mutant F361S is cross-resistant to antitumor rebeccamycin derivatives. A model for topoisomerase I inhibition by indolocarbazoles.

Bailly C, Carrasco C, Hamy F, Vezin H, Prudhomme M, Saleem A, Rubin E.

Biochemistry. 1999 Jul 6;38(27):8605-11.

PMID:
10393535
19.

Characterization of an altered DNA catalysis of a camptothecin-resistant eukaryotic topoisomerase I.

Gromova II, Kjeldsen E, Svejstrup JQ, Alsner J, Christiansen K, Westergaard O.

Nucleic Acids Res. 1993 Feb 11;21(3):593-600.

Supplemental Content

Support Center